Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation
Authors:
Open Access
- 30 January 2026
- journal article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (2) , 611-618
Abstract
Background/Aim: Urine cyclic guanosine monophosphate (cGMP) has been proposed as a prognostic biomarker for therapy response and the risk of relapse of cervical cancer after treatment with radiotherapy (RT). In the present study, an in vitro model with cervical cancer cells (C4-1) was established to determine whether changes in extracellular cGMP levels were predictive for effects of ionization radiation (IR). Materials and Methods: During exponential growth, C4-1 cells were exposed to IR with doses between 2 and 12 Gy. The cells were harvested at intervals between one and six days. Results: The effect of IR on cell growth and extracellular cGMP levels was dose- as well as time-dependent. Three and six days after IR, the cell fractions were reduced with identical sensitivity (ED50 of 1.9 and 1.8 Gy, respectively). The extracellular cGMP levels showed a fall from the first day to sixth day, both in control and after irradiation (2 and 4 Gy), but with somewhat higher levels after IR. However, the extracellular cGMP levels increased after 8 and 12 Gy exposure by 100% and 270%, respectively. When the data were presented as extracellular cGMP levels (% above control), a clear dose- and time-dependency were observed. Conclusion: From a translational perspective, extracellular cGMP levels may be used to monitor effects and be a potential tool for individualization of radiation therapy (RT).Keywords
This publication has 31 references indexed in Scilit:
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023Radiotherapy and Oncology, 2023
- Ionizing Radiation: Biologic Effects and Essential Cell Biology2022
- Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice GuidelinePractical Radiation Oncology, 2020
- Cervical cancer: Biomarkers for diagnosis and treatmentClinica Chimica Acta, 2015
- Guanylyl cyclase structure, function and regulationCellular Signalling, 2011
- Biomarkers and Surrogate Endpoints for Normal-Tissue Effects of Radiation Therapy: The Importance of Dose–Volume EffectsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Cell Density Dependence of cAMP and cGMP Levels in Four Human Cell Lines Derived from Carcinomas of the Uterine CervixGynecologic Oncology, 1994
- Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4‐i) and non‐transformed (WI‐38) human cellsInternational Journal of Cancer, 1993
- Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligandsJournal of Theoretical Biology, 1976